Health Condition 1: K35-K38- Diseases of appendix Health Condition 2: K20-K31- Diseases of esophagus, stomach and duodenum Health Condition 3: K00-K14- Diseases of oral cavity and salivary glands Health Condition 4: K65-K68- Diseases of peritoneum and retroperitoneum Health Condition 5: K80-K87- Disorders of gallbladder, biliary tract and pancreas Health Condition 6: K40-K46- Hernia Health Condition 7: A00-A09- Intestinal infectious diseases Health Condition 8: C50-C50- Malignant neoplasms of br
Conditions
Interventions
Intervention1: Ascorbic acid: 500 mg TDS for 10 days
Control Intervention1: Placebo: Streptococcus faecalis 30.0 M, Clostridium butyricum 2.0 M, Bacillus
mesentericus 1.0 M, Lactic acid bacillus 50.0
Sponsors
NIL
Eligibility
Inclusion criteria
Inclusion criteria: Patients undergoing elective general surgery Patients with negative pre-catheterization urine culture
Exclusion criteria
Exclusion criteria: Patients with mental disorders or illness who cannot understand or comply with the study protocol Patients with known drug allergy/contraindications to ascorbic acid Patients on antimicrobials Any patients with difficult catheterization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of catheter associated urinary tract infections in patients undergoing elective general surgeryTimepoint: Catheterization to 10 days post catheter removal | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment emergent adverse effects (TEAE)Timepoint: Catheterization to 10 days post catheter removal;Incidence of urosepsis as defined by SIRS criteriaTimepoint: Catheterization to 10 days post catheter removal;Complications of CAUTI and per urethral catheterization as per modified Clavien-Classification systemTimepoint: Catheterization to 10 days post catheter removal | — |
Countries
India
Contacts
Public ContactDr Navya Thakur
University college of medical sciences and Guru Teg Bahadur Hospital
Outcome results
None listed